Literature DB >> 10959073

Cardiovascular risk in diabetes: a brief review.

J B Marks1, P Raskin.   

Abstract

Cardiovascular disease (CVD) is the major cause of the morbidity and mortality associated with diabetes in the US. A 2- to 3-fold incidence of CVD occurs in both type 1 and type 2 diabetic individuals over that in age- and gender-matched non-diabetic persons. Recent encouraging data demonstrating a decline in CVD mortality in the general US population do not reflect such a decline in the diabetic population, particularly in women. Increased risk for CVD is related to duration of diabetes and hyperglycemia, as well as hypertension, dyslipidemia, insulin resistance, gender, coagulation abnormalities, and other factors. Health care providers need to advocate for an uncompromising, multi-component attack on all modifiable risk factors for CVD, including glucose control, in the person with diabetes mellitus. This review focuses on known modifiable risk factors for CVD associated with diabetes, potential targets for primary and secondary prevention.

Entities:  

Mesh:

Year:  2000        PMID: 10959073     DOI: 10.1016/s1056-8727(00)00065-9

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  26 in total

Review 1.  Exercise training: can it improve cardiovascular health in patients with type 2 diabetes?

Authors:  K J Stewart
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

2.  An illness behavior view on coping with diabetes.

Authors:  Bernt Lindahl
Journal:  Int J Behav Med       Date:  2008

3.  Time-course of vascular adaptations during 8 weeks of exercise training in subjects with type 2 diabetes and middle-aged controls.

Authors:  Tim H A Schreuder; Daniel J Green; Jean Nyakayiru; Maria T E Hopman; Dick H J Thijssen
Journal:  Eur J Appl Physiol       Date:  2014-09-27       Impact factor: 3.078

Review 4.  Role of lipotoxicity in endothelial dysfunction.

Authors:  Jeong-a Kim; Monica Montagnani; Sruti Chandrasekran; Michael J Quon
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

Review 5.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study.

Authors:  Josep Franch-Nadal; Fermín García-Gollarte; Alfonso Pérez Del Molino; María L Orera-Peña; Marta Rodríguez de Miguel; Malena Melogno-Klinkas; Héctor D de Paz; Susana Aceituno; Patricia Rodríguez-Fortúnez
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

7.  Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition.

Authors:  Hany M El-Bassossy; Mohamed A El-Moselhy; Mona F Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-29       Impact factor: 3.000

Review 8.  Blood pressure control--effects on diabetic nephropathy progression: how low does blood pressure have to be?

Authors:  Christopher A Newton; Philip Raskin
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

9.  Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial.

Authors:  G D Brinkworth; M Noakes; B Parker; P Foster; P M Clifton
Journal:  Diabetologia       Date:  2004-10-06       Impact factor: 10.122

10.  Electrocardiographic Left Ventricular Hypertrophy Among Gambian Diabetes Mellitus Patients.

Authors:  M Jobe; A Kane; J C Jones; S Pessinaba; B C Nkum; S Abdou Ba; O A Nyan
Journal:  Ghana Med J       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.